Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01384266 · ClinicalTrials.gov registry record
A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery
A clinical trial of Intraocular Inflammation, sponsored by Associated Eye Care, Minnesota.
- Completed
- Registry status
- 90
- Enrollment target
- 2
- Study locations
NCT01384266: Completed study of Intraocular Inflammation, sponsored by Associated Eye Care, Minnesota.
NCT01384266 is a study of Intraocular Inflammation that has completed, run by Associated Eye Care, Minnesota. The registered enrollment target is 90 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01384266, a study of Intraocular Inflammation, has completed, sponsored by Associated Eye Care, Minnesota.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
- 2
- Study locations
Study Summary
Patients are routinely given steroid eye drops following cataract surgery. This study will compare 2 approved drops:Loteprednol Etabonate versus Prednisolone Acetate Eye drops used following cataract surgery. Patients will be randomly assigned to one drop or the other, and evaluated for inflammation and intraocular pressure as part of the comparison. The study Doctor will be masked as to which drop the patient receives to avoid bias.
Primary Outcome
Slit Lamp examination will be done at each visit to grade intraocular inflammation
Conditions Studied
Study Locations (2)
Kentucky
- Cincinnati Eye Institute - Edgewood
Minnesota
- Associated Eye Care - Stillwater
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2010-05 |
| Est. Completion | 2011-11 |
What the finished NCT01384266 record still lists
NCT01384266 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 1 condition, with Intraocular Inflammation appearing as the primary indexed condition, and to 0 interventions.
NCT01384266 reports a single indexed study location in Kentucky, Minnesota.
Frequently Asked Questions
What is clinical trial NCT01384266 about?
NCT01384266 is a clinical study titled "A Comparison of 0.5% Loteprednol Etabonate Versus 1% Prednisolone Acetate Following Cataract Surgery". Patients are routinely given steroid eye drops following cataract surgery. This study will compare 2 approved drops:Loteprednol Etabonate versus Prednisolone Acetate Eye drops used following cataract surgery. Patients will be randomly assigned to one drop or the other, and evaluated for inflammation...
What is the current status of trial NCT01384266?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2010-05. Estimated completion is 2011-11.
What conditions does trial NCT01384266 study?
This clinical trial studies the following conditions: Intraocular Inflammation.
Who is sponsoring clinical trial NCT01384266?
This trial is sponsored by Associated Eye Care, Minnesota, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01384266 being conducted?
This trial has 2 study locations across Kentucky, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia